Alkermes plc.
For the period ended Dec 31, 2025. Filed Feb 25, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 25, 2026
ALKS$46.17+0.6%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
December 31, 2025 and 2024
| December 31, 2025 | December 31, 2024 | |
|---|---|---|
| (In thousands, except share and per share amounts) | ||
| ASSETS | ||
| CURRENT ASSETS: | ||
| Cash and cash equivalents | $388,570 | $291,146 |
| Restricted cash | 731,206 | — |
| Investments—short-term | 199,645 | 460,522 |
| Receivables, net | 334,025 | 384,528 |
| Inventory | 196,625 | 182,887 |
| Prepaid expenses and other current assets | 79,090 | 91,282 |
| Contract assets | — | 4,990 |
| Total current assets | 1,929,161 | 1,415,355 |
| PROPERTY, PLANT AND EQUIPMENT, NET | 221,722 | 227,564 |
| INVESTMENTS—LONG-TERM | 145 | 73,148 |
| RIGHT-OF-USE ASSETS | 77,209 | 84,245 |
| INTANGIBLE ASSETS, NET AND GOODWILL | 83,842 | 83,917 |
| DEFERRED TAX ASSETS | 125,815 | 154,835 |
| OTHER ASSETS | 49,099 | 16,503 |
| TOTAL ASSETS | $2,486,993 | $2,055,567 |
| LIABILITIES AND SHAREHOLDERS’ EQUITY | ||
| CURRENT LIABILITIES: | ||
| Accounts payable and accrued expenses | $289,565 | $185,332 |
| Accrued sales discounts, allowances and reserves | 247,126 | 272,452 |
| Operating lease liabilities—short-term | 6,746 | 6,166 |
| Contract liabilities—short-term | — | 1,249 |
| Total current liabilities | 543,437 | 465,199 |
| OPERATING LEASE LIABILITIES—LONG-TERM | 63,253 | 69,372 |
| OTHER LONG-TERM LIABILITIES | 61,008 | 56,019 |
| Total liabilities | 667,698 | 590,590 |
| COMMITMENTS AND CONTINGENT LIABILITIES (Note 19) | ||
| SHAREHOLDERS’ EQUITY: | ||
| Preferred shares, par value, $0.01 per share; 50,000,000 shares authorized; and zero issued and outstanding at December 31, 2025 and 2024 | — | — |
| Ordinary shares, par value, $0.01 per share; 450,000,000 shares authorized; 181,011,166 and 176,670,785 shares issued; and 165,607,028 and 162,176,994 shares outstanding at December 31, 2025 and 2024, respectively | 1,810 | 1,767 |
| Treasury shares, at cost (15,404,138 and 14,493,791 shares at December 31, 2025 and 2024, respectively) | (450,287) | (419,255) |
| Additional paid-in capital | 3,004,666 | 2,860,890 |
| Accumulated other comprehensive loss | (2,100) | (1,967) |
| Accumulated deficit | (734,794) | (976,458) |
| Total shareholders’ equity | 1,819,295 | 1,464,977 |
| TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY | $2,486,993 | $2,055,567 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.